Biomarkers are sold as the future of medicine — earlier diagnoses, personalized treatment, objective tracking of disease — but the science behind that promise is shakier than the marketing suggests. This episode pulls apart where biomarkers genuinely help versus where they fail to predict what actually matters: quality of life and long-term survival. The gap is even wider in psychology and psychiatry, where reaching for a biological number risks turning complex human conditions into oversimplified metrics. We make the case for treating biomarkers as fallible tools that demand skepticism and clinical judgment, not as shortcuts to certainty.

Self-surveys dominate psychology and social psychology because they are cheap and easy to administer. The correct question is not whether people can answer Likert items, but whether those answers remain comparable across people, groups, or decades and whether the resulting scores correspond to anything that actually matters.

Food marketing does not always require a false statement to mislead consumers. By emphasizing one beneficial nutrient while withholding information about quantity and competing food sources, advertisers can make an ordinary product appear nutritionally exceptional. This article examines how cherry-picking, selective framing, and the health-halo effect shape what consumers believe about food.

Carlos talks with Dr. Brown about how flawed studies make it into publication and, from there, into headlines people trust. The conversation digs into common red flags — small sample sizes, p-hacking, conflicts of interest, and cherry-picked data — that separate rigorous science from spin dressed up as research. It's a practical guide to reading a study more critically before believing the claim built on top of it.

This episode examines the controversial diagnostic history and neuroscientific claims surrounding Dissociative Identity Disorder, pitting popular trauma-model narratives against rigorous scientific scrutiny. We analyze the strength of current neuroimaging evidence, evaluate methodological limitations in clinical studies, and explore how media portrayals and institutional biases can inflate diagnostic claims. By cutting through the noise of social media trends and therapeutic hype, we separate empirically validated research from iatrogenic artifacts to uncover what the data actually says about complex trauma and the human brain.

Popular trauma narratives claim that chronic stress reshapes the brain and body in ways that inevitably impair focus, flexibility, and emotional control while damaging physical health. This episode examines the evidence behind those claims, separating well-supported findings from oversimplified interpretations. We explore how neuroimaging, physiology, and animal research contribute to our understanding—and where the science is more uncertain than commonly portrayed.

Across decades of public health data, researchers have noticed a stunning trend: as global education rates climb, age-adjusted dementia numbers are beginning to drop. This episode breaks down the complex longitudinal studies tracking how even a single additional year of schooling correlates with a significantly delayed onset of cognitive decline. We analyze the variables at play, investigating whether degrees themselves protect the mind or if they simply act as a proxy for healthier lifelong habits.

Recent epidemiological data shows a devastating rise in aggressive, early-onset cancers among adults who experienced metabolic dysfunction before age 30. This episode examines the precise biomolecular pathways—including hyperinsulinemia, altered cytokine signaling, and chronic systemic inflammation—that accelerate tumor development in adipose tissue environments. Join clinical researchers as they dissect the newest peer-reviewed oncology studies to understand how early-life obesity fundamentally alters cellular mutation rates.

This podcast evaluates the scientific evidence supporting and questioning the role of sunscreen in melanoma prevention, drawing on randomized controlled trials, observational studies, and meta-analyses while addressing key limitations. It examines the interplay between sunscreen use and vitamin D synthesis, presenting arguments for potential interference alongside real-world data indicating minimal clinical impact. A balanced conclusion emphasizes evidence-based sun protection strategies tailored to individual risk profiles, particularly for high-risk ethnic groups in sunny environments.

This podcast episode explores the use of surrogate endpoints versus patient-important clinical outcomes in medical and psychological research studies, highlighting their role in accelerating trials while cautioning against over-reliance. It presents advantages such as faster, less expensive studies alongside critical limitations, including frequent failures to predict real clinical benefit as seen in cardiovascular, oncology, and Alzheimer’s research. Listeners receive a balanced framework for critically appraising research that employs surrogate markers.